The White House is considering Michael Burgess, a retired Texas physician and former Republican representative, for CDC director after withdrawing Dave Weldon's nomination. Burgess, known for ...
The White House is considering former Republican Representative Michael Burgess to run the U.S. Centers for Disease Control ...
The president's pick will be the first CDC director to undergo the Senate confirmation process after a change passed by Congress in 2022 . Any nominee will face tough questions over a range of health ...
biologic therapies," said David Reese, Amgen's R&D head. "We look forward to working with regulators to make this potential biosimilar option available to patients." Complement C5 inhibitor ...
French drugmaker Sanofi has halted the development of its antibody-drug conjugate (ADC) tusamitamab ravtansine after the drug failed a phase 3 trial in non-small cell lung cancer (NSCLC).
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
The Capital Structure page of Tata Consultancy Services Ltd. presents the Authorized Capital, Issued Capital, and Paid-Up Equity Capital of the company over the period. Capital Structure - Tata ...